This lack of clinical responsiveness may be due to the restricted pattern of viral latent antigen expression in cancer cells, the poor immunogenicity of EBV proteins (LMP1, LMP2 and EBNA1) expressed in NPC cells and a local immunosuppressive TME. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.